I60-I69 G62.80 G72.80 S06 G93 G82 G93 G61
Conditions
Interventions
Group 1: Usability and Feasability:
Observation during therapy (6 therapies per patient) with therapists, nurses and patients
after therapy block:
> questions to the participants / users:
Nurses and
Sponsors
Schön Klinik Bad Aibling Harthausen
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: • neuro Reha- Phase B and C patients • Barthel Index 18 years • Weight:> 45kg, 1,50m, <1,95m • Diagnoses: TBI, stroke (ICB or ischemic) or hypoxic brain damage, CIP / CIM, GBS, paraplegia • Intensive surveillance DOC (n = 6) • MCS = minimally conscious state or RW: unresponsiveness, classification based on the CRS-r scale (according to (Giacino et al., 2004) Non-DOC (n = 6) • Patients without DOC symptoms (classification also based on the CRS-r scale) • Orientation to the person and situation • German Speaking
Exclusion criteria
Exclusion criteria: • patients in intensive care • ventilation • Severe contractures, severe spasticity (MAS1> 3) • Myocardial infarction <4 weeks before study • Pacemaker • severe osteoporosis • Decubitus or unstable fractures on treatment-relevant areas
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Investigate the safe applicability of VEMO therapy and ease of use (workload and usability) among all individuals involved (patients, therapists, nurses). Establishment of an optimized usage protocol. | — |
Secondary
| Measure | Time frame |
|---|---|
| Obtaining information for further technical development and optimization of the VEMO (eg autoadaptivity, Assist-as-Needed function) as well as for the derivation of an optimal implementation strategy of the robotic device into the clinical routine. | — |
Countries
Germany
Contacts
Public ContactFriedemann Müller
Schön Klinik Bad Aibling SE & Co. KG
Outcome results
None listed